Biotechnology in the News

Generex Biotechnology Corporation is involved with pharmaceutical and biotechnological research and improvement medication delivery methods and technologies, as well as other activities. The organization offers a platform technology when it comes to management of formulations of big molecule drugs into dental (buccal) hole making use of a hand-held aerosol applicator. It develops drug distribution methods and technologies for metabolic and immunological conditions. The business is performing pre-clinical and human clinical tests having its technology platforms inside areas of diabetic issues, discomfort management and cancers. Its buccal insulin item, Generex Oral-lyn, provides a needle-free method of delivering insulin when it comes to patients enduring type I diabetes and type II diabetes. Its buccal distribution technology involves the planning of formulations for which an active pharmaceutical broker is put in an answer with a combination of absorption enhancers and other excipients.